Staphefekt
Staphefekt is a proprietary enzyme developed by the Dutch biotech company Micreos. It is specifically designed to target and kill Staphylococcus aureus, a type of bacteria that can cause a variety of infections in humans. Staphefekt is unique in its ability to selectively target and kill both antibiotic-resistant and antibiotic-sensitive strains of Staphylococcus aureus, without harming beneficial bacteria.
Mechanism of Action[edit | edit source]
Staphefekt works by binding to the cell wall of Staphylococcus aureus bacteria and breaking down its structure, leading to the death of the bacteria. This mechanism of action is different from antibiotics, which typically inhibit the growth and reproduction of bacteria. Because of this unique mechanism, Staphefekt is not affected by antibiotic resistance and can effectively kill strains of Staphylococcus aureus that are resistant to multiple antibiotics.
Applications[edit | edit source]
Staphefekt has potential applications in a variety of medical fields. It is currently used in a topical cream called Gladskin, which is used to treat skin conditions such as eczema, rosacea, and acne. Because it selectively targets Staphylococcus aureus, it can help to restore the natural balance of the skin microbiome in these conditions.
In addition to its use in dermatology, Staphefekt may also have potential applications in the treatment of systemic Staphylococcus aureus infections, such as sepsis, endocarditis, and pneumonia. However, more research is needed to determine the safety and efficacy of Staphefekt in these applications.
Safety and Efficacy[edit | edit source]
Staphefekt has been shown to be safe and effective in clinical trials. In a study of patients with eczema, treatment with Gladskin cream containing Staphefekt resulted in a significant reduction in Staphylococcus aureus levels on the skin, as well as improvements in eczema symptoms.
However, as with any new treatment, more research is needed to fully understand the long-term safety and efficacy of Staphefekt.
See Also[edit | edit source]
References[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
